^
    Apply
    Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. (NCT02903771)
    Phase 1
    Kazia Therapeutics Limited
    Completed
    Last update posted :
    04/20/2020
    Initiation :
    11/01/2016
    Primary completion :
    03/24/2020
    Completion :
    03/24/2020
    BRCA
    |
    Cantrixil (TRX-E-002-1)